UTHR

UNITED THERAPEUTICS Corp

SEC CIK 1082554
$545.96 +13.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$276.92M
528 open-market
Net insider flow
−$276.92M
Net selling
Filings shown
726
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at UTHR have sold a net $276.92M of stock (0 open-market buys vs 528 sells).

Largest recent trade: Mahon Paul A sold $2.88M of UTHR, trimming their stake 17%.

Most active filer: Rothblatt Martine A, with 428 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for UTHR, newest first
View on SEC EDGAR ↗
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 6d ago ΔOwn −3.2%

Rothblatt Martine A sold $838.6K of UTHR, trimming their stake 3%.

−$838.6K
1,534 sh @ $547
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 6d ago ΔOwn −3.2%

Rothblatt Martine A sold $821K of UTHR, trimming their stake 3%.

−$821K
1,499 sh @ $548
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 6d ago ΔOwn −0.6%

Rothblatt Martine A sold $153.7K of UTHR, trimming their stake 1%.

−$153.7K
280 sh @ $549
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 6d ago ΔOwn −1.1%

Rothblatt Martine A sold $263.9K of UTHR, trimming their stake 1%.

−$263.9K
480 sh @ $550
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 6d ago ΔOwn −2.9%

Rothblatt Martine A sold $727.8K of UTHR, trimming their stake 3%.

−$727.8K
1,320 sh @ $551
Advertisement
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 6d ago ΔOwn −6.3%

Rothblatt Martine A sold $1.52M of UTHR, trimming their stake 6%.

−$1.52M
2,760 sh @ $552
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 6d ago ΔOwn −0.5%

Rothblatt Martine A sold $121.6K of UTHR, trimming their stake 1%.

−$121.6K
220 sh @ $553
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 1w ago ΔOwn −5.4%

Edgemond James sold $852.8K of UTHR, trimming their stake 5%.

−$852.8K
1,565 sh @ $545
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 1w ago ΔOwn −7.3%

Edgemond James sold $1.09M of UTHR, trimming their stake 7%.

−$1.09M
1,989 sh @ $546
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 1w ago ΔOwn −7.5%

Edgemond James sold $1.03M of UTHR, trimming their stake 7%.

−$1.03M
1,888 sh @ $547
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 1w ago ΔOwn −9.2%

Edgemond James sold $1.18M of UTHR, trimming their stake 9%.

−$1.18M
2,158 sh @ $548
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 1w ago ΔOwn −2.0%

Edgemond James sold $233.5K of UTHR, trimming their stake 2%.

−$233.5K
425 sh @ $549
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 1w ago ΔOwn −6.2%

Edgemond James sold $706.9K of UTHR, trimming their stake 6%.

−$706.9K
1,285 sh @ $550
UTHR
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 1w ago ΔOwn −3.1%

Edgemond James sold $336.3K of UTHR, trimming their stake 3%.

−$336.3K
610 sh @ $551
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 1w ago ΔOwn −2.9%

Rothblatt Martine A sold $796.6K of UTHR, trimming their stake 3%.

−$796.6K
1,462 sh @ $545
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 1w ago ΔOwn −4.4%

Rothblatt Martine A sold $1.16M of UTHR, trimming their stake 4%.

−$1.16M
2,131 sh @ $546
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 1w ago ΔOwn −3.3%

Rothblatt Martine A sold $834.3K of UTHR, trimming their stake 3%.

−$834.3K
1,525 sh @ $547
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 1w ago ΔOwn −4.8%

Rothblatt Martine A sold $1.17M of UTHR, trimming their stake 5%.

−$1.17M
2,144 sh @ $548
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 1w ago ΔOwn −2.2%

Rothblatt Martine A sold $521K of UTHR, trimming their stake 2%.

−$521K
948 sh @ $550
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 1w ago ΔOwn −1.6%

Rothblatt Martine A sold $357.8K of UTHR, trimming their stake 2%.

−$357.8K
650 sh @ $550
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 1w ago ΔOwn −1.6%

Rothblatt Martine A sold $352.9K of UTHR, trimming their stake 2%.

−$352.9K
640 sh @ $551
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 1w ago ΔOwn −3.5%

Rothblatt Martine A sold $948.4K of UTHR, trimming their stake 3%.

−$948.4K
1,737 sh @ $546
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 1w ago ΔOwn −5.8%

Rothblatt Martine A sold $1.54M of UTHR, trimming their stake 6%.

−$1.54M
2,808 sh @ $547
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 1w ago ΔOwn −5.2%

Rothblatt Martine A sold $1.3M of UTHR, trimming their stake 5%.

−$1.3M
2,366 sh @ $548
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 1w ago ΔOwn −3.0%

Rothblatt Martine A sold $707.4K of UTHR, trimming their stake 3%.

−$707.4K
1,289 sh @ $549
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 1w ago ΔOwn −2.9%

Rothblatt Martine A sold $660.8K of UTHR, trimming their stake 3%.

−$660.8K
1,202 sh @ $550
Advertisement

About UTHR insider activity

This page tracks every recent Form 4 filed for UNITED THERAPEUTICS Corp with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is UTHR insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for UNITED THERAPEUTICS Corp usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.